Santhera Pharmaceuticals Holding AG
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Santhera Pharmaceuticals Holding AG generated cash of $47,271,000, which is more than the previous year. Cash used in financing activities reached the amount of -$171,000 last year. Net change in cash is therefore $29,017,000.
Cash Flow
| 2014 | -6.06M | -207K | 18.66M |
|---|---|---|---|
| 2015 | -22.39M | -619K | 82.63M |
| 2016 | -27.13M | -459K | 631K |
| 2017 | -39.63M | -22.23M | 57.10M |
| 2018 | -37.86M | -5.90M | 20.64M |
| 2019 | 2.59M | 2.78M | 4.12M |
| 2020 | -43.51M | 1.56M | 23.15M |
| 2021 | -37.35M | 69K | 46.02M |
| 2022 | -29.84M | -3.93M | 13.99M |
| 2023 | 47.27M | -18.04M | -171K |
SANN.SW Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 1.35M | 21.20M | 12.41M | 31.35M | 21.97M | 45.19M | 49.81M | 76.85M | 17.43M | 5.04M |
Operating activities | ||||||||||
Net income | 54.78M | -70.61M | -54.71M | -67.45M | -18.39M | -53.86M | -51.27M | -33.19M | 2.93M | -7.53M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 3.04M | 9.85M | 3.72M | 7.13M | 4.77M | 3.74M | 3.38M | 3.26M | 1.12M | 75K |
Stock-based compensation expense | 5.99M | 5.45M | 2.76M | 3.02M | 6.25M | 0 | 9.68M | 4.68M | 2.04M | 759K |
| Deferred income tax benefit | 5.99M | 5.45M | 2.76M | 3.02M | 6.25M | 0 | 9.68M | 4.68M | 2.04M | 759K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | 47.27M | -29.84M | -37.35M | -43.51M | 2.59M | -37.86M | -39.63M | -27.13M | -22.39M | -6.06M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | -13.34M | -84K | -104K | 0 |
Investments In Property Plant And Equipment | -90K | -3.95M | -15K | -34K | -229K | -21.64M | -1.39M | -375K | -515K | -207K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -18.04M | -3.93M | 69K | 1.56M | 2.78M | -5.90M | -22.23M | -459K | -619K | -207K |
Financing activities | ||||||||||
Common Stock Issued | 18.82M | 511K | 20.35M | 901K | 8.95M | 25.79M | 9.40M | 803K | 84.57M | 18.98M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | -56K | -922K | -1.83M | -3.41M | -9.56M | -172K | 0 | 0 |
Repayments of term debt | -17.97M | 14.55M | -3.5M | -24.55M | 0 | 0 | 57.26M | 0 | 0 | 0 |
Cash used in financing activities | -171K | 13.99M | 46.02M | 23.15M | 4.12M | 20.64M | 57.10M | 631K | 82.63M | 18.66M |
Net Change In Cash | 29.01M | -19.85M | 8.79M | -18.94M | 9.38M | -23.22M | -4.62M | -27.04M | 59.42M | 12.39M |
Cash at end of period | 30.37M | 1.35M | 21.20M | 12.41M | 31.35M | 21.97M | 45.19M | 49.81M | 76.85M | 17.43M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |